Total Funding
78
43
Total FundingSeries A raised
Growth Score
-2 pts
Heat Score
0 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
36051
I2o Therapeutics is a biotech company that develops safe and effective oral formulations of therapies.
Samir Mitragotri: Co-FounderPast Role: University of California, Santa Barbara, Professor of Chemical Engineering- Kurt Graves: Chairman, President & CEOPast Role: Vertex Pharmaceuticals, Chief Commercial Officer & Head of Corporate & Strategic Drug Development
About the Company
i2o Therapeutics is a biotech company that develops safe and effective oral formulations of therapies traditionally limited to injections. Using an innovative ionic liquid technology, it leverages the benefits of protecting the drug cargo while also transiently enhancing permeation across the epithelial lining when administered orally. i2o is
focused on creating the next generation of oral peptide and protein-based therapies.
The company was founded in 2019 and based in Saratoga, California.
